49.99
price up icon7.96%   2.99
 
loading
Schlusskurs vom Vortag:
$47.00
Offen:
$48.12
24-Stunden-Volumen:
42,471
Relative Volume:
0.36
Marktkapitalisierung:
$460.68M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.17M
KGV:
-
EPS:
-
Netto-Cashflow:
$-82.84M
1W Leistung:
+2.09%
1M Leistung:
-33.11%
6M Leistung:
-0.12%
1J Leistung:
+31.31%
1-Tages-Spanne:
Value
$47.41
$51.50
1-Wochen-Bereich:
Value
$44.65
$51.50
52-Wochen-Spanne:
Value
$30.00
$98.00

Korro Bio Inc Stock (KRRO) Company Profile

Name
Firmenname
Korro Bio Inc
Name
Telefon
617-468-1999
Name
Adresse
60 FIRST STREET, CAMBRIDGE
Name
Mitarbeiter
101
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-08
Name
Neueste SEC-Einreichungen
Name
KRRO's Discussions on Twitter

Vergleichen Sie KRRO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
KRRO 50.83 460.68M 0 -81.17M -82.84M 0.00
VRTX 450.67 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.27 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 591.22 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.29 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.27 24.89B 3.30B -501.07M 1.03B 11.54

Korro Bio Inc Stock (KRRO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-03-28 Bestätigt H.C. Wainwright Buy
2024-02-27 Eingeleitet BMO Capital Markets Outperform
2023-12-04 Eingeleitet H.C. Wainwright Buy
2023-11-29 Eingeleitet RBC Capital Mkts Outperform
2023-11-10 Eingeleitet Piper Sandler Overweight
2023-02-15 Herabstufung Chardan Capital Markets Buy → Neutral
2023-02-13 Herabstufung Cowen Outperform → Market Perform
2021-09-22 Herabstufung Goldman Buy → Neutral
2021-01-27 Hochstufung JP Morgan Neutral → Overweight
2020-12-22 Eingeleitet B. Riley Securities Buy
2020-07-14 Eingeleitet Oppenheimer Outperform
2020-05-18 Herabstufung JP Morgan Overweight → Neutral
2019-10-28 Eingeleitet Cowen Outperform
2019-10-28 Eingeleitet Goldman Buy
2019-10-28 Eingeleitet JP Morgan Overweight
Alle ansehen

Korro Bio Inc Aktie (KRRO) Neueste Nachrichten

pulisher
07:48 AM

Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency - The Manila Times

07:48 AM
pulisher
Nov 18, 2024

Jones Trading Initiates Coverage of Korro Bio (KRRO) with Buy Recommendation - MSN

Nov 18, 2024
pulisher
Nov 18, 2024

Korro Bio FY2024 EPS Forecast Increased by HC Wainwright - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

William Blair Has Positive View of Korro Bio FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Eventide Asset Management's Strategic Reduction in Korro Bio Inc Holdings - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Deep Track Capital, LP's Strategic Acquisition of Korro Bio Inc Shares - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Korro to Present at the Jefferies London Healthcare Conference - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Korro Bio to Present RNA-Editing Breakthroughs at Jefferies London Healthcare Conference | KRRO Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

Korro Bio’s Progress and Financial Updates - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for growth - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

William Blair Reiterates "Outperform" Rating for Korro Bio (NASDAQ:KRRO) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

FMR LLC Reduces Stake in Korro Bio Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Korro Bio CFO Vineet Agarwal sells $56,000 in stock - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Korro Bio CFO Vineet Agarwal sells $56,000 in stock By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Korro Bio Partners with Novo Nordisk, Reports $169M Cash Position Despite Widening Losses | KRRO Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 08, 2024

4 Biotech Stocks With AI, Machine Learning Prowess - Investing.com

Nov 08, 2024
pulisher
Nov 07, 2024

Korro Bio (NASDAQ:KRRO) Stock Price Up 10.9%Here's What Happened - MarketBeat

Nov 07, 2024
pulisher
Nov 05, 2024

Korro Bio files in Australia to begin first-in-human study of KRRO-110 for AATD - BioWorld Online

Nov 05, 2024
pulisher
Nov 04, 2024

Korro Bio (NASDAQ:KRRO) Shares Gap DownHere's Why - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Korro Bio, Inc. Announces Submission to Bellberry HREC for Phase 1/2 Clinical Study of KRRO-110 for AATD - Marketscreener.com

Nov 04, 2024
pulisher
Oct 28, 2024

Korro Bio (NASDAQ:KRRO) Trading Down 5.1%Time to Sell? - MarketBeat

Oct 28, 2024
pulisher
Oct 25, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for clinical leap - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for clinical leap By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 23, 2024

Korro Bio (NASDAQ:KRRO) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Korro Bio (NASDAQ:KRRO) Coverage Initiated at Raymond James - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

RBC lifts Korro Bio stock target on positive RNA editing outlook - Investing.com Australia

Oct 22, 2024
pulisher
Oct 22, 2024

Raymond James Initiates Coverage of Korro Bio (KRRO) with Strong Buy Recommendation - MSN

Oct 22, 2024
pulisher
Oct 21, 2024

Korro Bio price target raised to $105 from $95 at RBC Capital - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

RBC lifts Korro Bio stock target on positive RNA editing outlook By Investing.com - Investing.com South Africa

Oct 21, 2024
pulisher
Oct 21, 2024

Royal Bank of Canada Boosts Korro Bio (NASDAQ:KRRO) Price Target to $105.00 - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Korro Bio initiated with a Strong Buy at Raymond James - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 21, 2024
pulisher
Oct 19, 2024

Korro bio CFO Vineet Agarwal sells $799,526 in stock - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

Insider Selling: Korro Bio, Inc. (NASDAQ:KRRO) CFO Sells 10,216 Shares of Stock - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Korro bio CFO Vineet Agarwal sells $799,526 in stock By Investing.com - Investing.com Australia

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio shares target lifted, buy rating on RNA editing potential - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio (NASDAQ:KRRO) Trading Down 4.1%Should You Sell? - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

HC Wainwright Increases Korro Bio (NASDAQ:KRRO) Price Target to $115.00 - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio price target raised to $115 from $100 at H.C. Wainwright - TipRanks

Oct 18, 2024
pulisher
Oct 17, 2024

BMO maintains steady target on Korro Bio shares By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 17, 2024

Wave data propel RNA-editing stocks, but are all platforms created equal? - BioCentury

Oct 17, 2024
pulisher
Oct 16, 2024

500: Something went wrong - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

180 Life Sciences, Korro Bio, NuScale Power: Retail Investors Turn Most Bullish On These Stocks - Barchart

Oct 16, 2024
pulisher
Oct 16, 2024

BMO maintains steady target on Korro Bio shares - Investing.com India

Oct 16, 2024
pulisher
Oct 16, 2024

What is KRRO’s price-to-sales ratio telling us about the company’s value? - US Post News

Oct 16, 2024
pulisher
Oct 16, 2024

Korro Bio (NASDAQ:KRRO) Shares Gap UpTime to Buy? - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Wall Street Analysts Think Korro Bio, Inc. (KRRO) Could Surge 239.54%: Read This Before Placing a Bet - Yahoo Finance UK

Oct 16, 2024

Finanzdaten der Korro Bio Inc-Aktie (KRRO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Korro Bio Inc-Aktie (KRRO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Agarwal Vineet
Chief Financial Officer
Nov 11 '24
Sale
70.00
800
56,000
0
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):